X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA CADILA HEALTHCARE ELDER PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x -0.2 35.8 - View Chart
P/BV x 0.1 9.2 1.1% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
CADILA HEALTHCARE
Mar-16
ELDER PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs380454 83.6%   
Low Rs188305 61.7%   
Sales per share (Unadj.) Rs491.296.1 511.2%  
Earnings per share (Unadj.) Rs-3.214.9 -21.4%  
Cash flow per share (Unadj.) Rs14.417.8 80.8%  
Dividends per share (Unadj.) Rs03.20 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.552.3 720.2%  
Shares outstanding (eoy) m20.541,023.74 2.0%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x0.63.9 14.6%   
Avg P/E ratio x-89.325.5 -349.9%  
P/CF ratio (eoy) x19.721.3 92.6%  
Price / Book Value ratio x0.87.3 10.4%  
Dividend payout %021.5 0.0%   
Avg Mkt Cap Rs m5,833388,458 1.5%   
No. of employees `000NA15.4 0.0%   
Total wages/salary Rs m2,17913,317 16.4%   
Avg. sales/employee Rs ThNM6,371.1-  
Avg. wages/employee Rs ThNM862.4-  
Avg. net profit/employee Rs ThNM986.1-  
INCOME DATA
Net Sales Rs m10,08998,376 10.3%  
Other income Rs m257941 27.3%   
Total revenues Rs m10,34699,317 10.4%   
Gross profit Rs m-79223,829 -3.3%  
Depreciation Rs m3613,022 12.0%   
Interest Rs m2,756486 567.1%   
Profit before tax Rs m-3,65321,262 -17.2%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m3,713-25 -14,850.8%   
Tax Rs m1255,716 2.2%   
Profit after tax Rs m-6515,226 -0.4%  
Gross profit margin %-7.824.2 -32.4%  
Effective tax rate %-3.426.9 -12.7%   
Net profit margin %-0.615.5 -4.2%  
BALANCE SHEET DATA
Current assets Rs m9,24044,376 20.8%   
Current liabilities Rs m9,99834,071 29.3%   
Net working cap to sales %-7.510.5 -71.7%  
Current ratio x0.91.3 71.0%  
Inventory Days Days4654 86.0%  
Debtors Days Days6062 96.1%  
Net fixed assets Rs m10,12447,896 21.1%   
Share capital Rs m2061,024 20.1%   
"Free" reserves Rs m5,58248,746 11.5%   
Net worth Rs m7,73453,519 14.5%   
Long term debt Rs m4,8898,964 54.5%   
Total assets Rs m22,882100,163 22.8%  
Interest coverage x-0.344.7 -0.7%   
Debt to equity ratio x0.60.2 377.4%  
Sales to assets ratio x0.41.0 44.9%   
Return on assets %11.815.7 75.0%  
Return on equity %-0.828.4 -3.0%  
Return on capital %22.334.3 65.1%  
Exports to sales %3.045.3 6.7%   
Imports to sales %0.45.9 7.2%   
Exports (fob) Rs m30744,537 0.7%   
Imports (cif) Rs m435,838 0.7%   
Fx inflow Rs m30744,881 0.7%   
Fx outflow Rs m1259,069 1.4%   
Net fx Rs m18135,812 0.5%   
CASH FLOW
From Operations Rs m11,75419,938 59.0%  
From Investments Rs m-561-9,039 6.2%  
From Financial Activity Rs m-6,762-9,527 71.0%  
Net Cashflow Rs m4,4321,372 323.0%  

Share Holding

Indian Promoters % 39.6 74.8 52.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 8.3 90.4%  
FIIs % 16.8 5.9 284.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 11.0 328.2%  
Shareholders   16,479 44,069 37.4%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   TORRENT PHARMA  NATCO PHARMA  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS